Supernus Pharms Drug Patent Portfolio

Supernus Pharms's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Supernus Pharms News

Key Highlights for Branded Pharmaceutical Stocks in Q2: Collegium Pharmaceutical (NASDAQ:COLL)

25 Sep, 2025

Analyzing the Q2 Earnings of Branded Pharmaceutical Stocks: A Look at Royalty Pharma (NASDAQ:RPRX)

11 Aug, 2025

See More